2-Ethylphenylhydrazine Hydrochloride → 3-(4,6-Dimethoxypyrimidine-2-yl)-2-methyl-7-ethylindole

HRID 2112238

Reaktionsgleichung

Reaktionsgleichung von HRID 2112238
[CH3:1][O:2][C:3]1[CH:8]=[C:7]([O:9][CH3:10])[N:6]=[C:5]([CH2:11][C:12](=O)[CH3:13])[N:4]=1.Cl.[CH2:16]([C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=1[NH:24]N)[CH3:17]>[Cl-].[Zn+2].[Cl-].C1(C)C=CC=CC=1>[CH3:1][O:2][C:3]1[CH:8]=[C:7]([O:9][CH3:10])[N:6]=[C:5]([C:11]2[C:20]3[C:19](=[C:18]([CH2:16][CH3:17])[CH:23]=[CH:22][CH:21]=3)[NH:24][C:12]=2[CH3:13])[N:4]=1

Komponenten

5

Versuchsvorschrift

Into a reactor were fed 2.4 g (12.2 m moles) of 1-(4,6-dimethoxypyrimidine-2-yl)-2-propanone, 1.7 g (9.98 m moles) of 2-ethylphenylhydrazine hydrochloride, 1.4 g (10.2 m moles) of zinc chloride and 10 ml of toluene, followed by refluxing for 2 hours with heating. After the completion of the reaction, the reaction mixture was cooled to room temperature. Thereto were added water and ethyl acetate and phase separation was made. The ethyl acetate layer was concentrated. The concentrate was subjected to silica gel column chromatography separation (developing solvent: n-hexane/ethyl acetate) to obtain 2.38 g (8.01 m moles) of 3-(4,6-dimethoxypyrimidine-2-yl)-2-methyl-7-ethylindole.

Aufarbeitung

  1. customInto a reactor were fed
  2. temperatureby refluxing for 2 hours
  3. temperaturewith heating
  4. customAfter the completion of the reaction
  5. additionThereto were added
  6. customwater and ethyl acetate and phase separation
  7. concentrationThe ethyl acetate layer was concentrated
  8. customThe concentrate was subjected to silica gel column chromatography separation (developing solvent: n-hexane/ethyl acetate)

Quellen und Nachweise

ORD-Eintrag
ord-d5dd7006af684a17bdf278abd529a45d
Quelldatensatz
uspto-grants-2009_04
Patentnummer
US07521555B2

Verknüpfte Notizen

Wird geladen…